ImmunoPhotonics: Funding, Investors & Team (Oct 2026)
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri.
ImmunoPhotonics has raised $34.9M across 3 funding rounds on record, the most recent a Series C of $10.0M announced in Sep 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ImmunoPhotonics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
ImmunoPhotonics Funding Rounds
ImmunoPhotonics raised $21.4M in a Series B announced in Apr 2022.
10 months later, an undisclosed round of $3.5M was announced in Feb 2023.
3.6 years later, a Series C of $10.0M was announced in Sep 2026.
ImmunoPhotonics Investors
13 investors are recorded in total; the 5 named above are those the record identifies.
ImmunoPhotonics Founders and Leadership Team
Contact details for the ImmunoPhotonics team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →ImmunoPhotonics Funding Compared to Other Biotechnology Startups
ImmunoPhotonics' latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ImmunoPhotonics in Biotechnology and Columbia
Companies Similar to ImmunoPhotonics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
ImmunoPhotonics Funding FAQs
What does ImmunoPhotonics do?
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri.
How much funding has ImmunoPhotonics raised?
ImmunoPhotonics has raised $34.9M across 3 rounds on record. The most recent is a Series C of $10.0M announced in Sep 2026.
When did ImmunoPhotonics last raise funding?
ImmunoPhotonics' most recent funding round on record is a Series C of $10.0M, announced in Sep 2026.
Who has invested in ImmunoPhotonics?
Investors on record for ImmunoPhotonics include Cultivation Capital, Arch Grants, iSelect Fund, TCA Venture Group, BioGenerator. FundedIQ records 13 investors in total.
Who founded ImmunoPhotonics?
FundedIQ lists Tomas Hode (Founder) at ImmunoPhotonics.
Who is the CEO of ImmunoPhotonics?
Miguel Ada is listed as Chief Executive Officer at ImmunoPhotonics.
Where is ImmunoPhotonics headquartered?
ImmunoPhotonics is based in Columbia, Missouri, United States.
How many employees does ImmunoPhotonics have?
ImmunoPhotonics is in the 11-50 employee band.
When was ImmunoPhotonics founded?
ImmunoPhotonics was founded in 2008.
How does ImmunoPhotonics' funding compare to other Biotechnology startups?
ImmunoPhotonics' latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ImmunoPhotonics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ImmunoPhotonics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.